 |
We are fully handicapped - accessible |
Founded in 1898, Weill Cornell Medical Center is among the top-ranked clinical and medical research centers in the nation. WCMC consists of both the medical school and the graduate school, and a successful clinical partnership with New York Hospital since 1927 (now called the Greenberg Pavilion, Cornell Campus-New York Presbyterian Hospital), located on the same campus. This medical complex has enhanced clinical and translational collaborations between physicians and researchers over many years. It has 1,900 full-time faculty conducting research and providing training and education to approximately 365 medical students, and 109 MD/PhD, 414 graduate students and 300+ post-doctoral fellows enrolled in the Graduate School. It has a significant portfolio of basic clinical and translation research.
The constituents of the center are:
Weill Cornell Medical College of Cornell University, New York City, established in 1898, has more than a century of experience in medical education, biomedical research, and healthcare and has one of the first federally funded Clinical Research Centers in the nation. WCMC is one of 13 colleges and schools comprising Cornell University. The University currently has three Nobel laureates and five former Nobel Laureates; 19 Nobel Laureates were former faculty members and 12 were former alumni.
The Medical College provides students with the diverse clinical opportunities of a large urban area. It was one of the first coeducational medical schools, and one of the first to require a degree from an undergraduate college as a standard for admission. Traditionally, 40%-60% of medical students engage in some basic or clinical research by graduation. Since 1974, Weill Cornell has fostered the educational pursuits of minority students and boasts a record of graduating over 400 minority physicians with numbers still rising. The class of 2005 was composed of 31% minority students.
The Medical College is rich in resources that are available for development of a well-integrated comprehensive translational research program. They include: (1) Clinical and scientific core facilities with instruction available to Trainees conducting their clinical research projects; (2) Centers of special interest to be used as resources for Trainees; (3) Clinical investigators from a variety of disciplines, specialties and subspecialties with mentoring expertise working in a multidisciplinary environment; and (4) Diverse and specialized inpatient and outpatient populations from the Cornell Campus of NYPH, and the hospitals affiliated with Weill Cornell Medical Center.
Located on the medical school campus, WGSMS was founded in 1952 and is under the auspices of the Cornell University Graduate School in Ithaca. The faculty and students will provide: trainees for clinical and translational research training; and basic and translational researchers to engage in team research in translational science.
The Graduate School has ten fully integrated multi-disciplinary graduate PhD programs with most areas of concentration relevant to translational research. There are approximately 220 faculty members at WGSMS with joint appointments at WMC and MSKCC: 40% have a primary appointment at the Sloan Kettering Institute and 60% at Weill Medical College. This is a unique integration of two institutions where courses are taught jointly and governance is by committees composed of faculty from both institutions.
Its programs include the NIH K-30/Masters Degree Program in Clinical Investigation, a program emphasizing multidisciplinary core curriculum and clinical and translational team research and a Masters in Epidemiology and Health Services Research. A combined MD/PhD degree is offered as well.
Weill Cornell Medical School’s affiliation with New York Hospital relates back to 1912 when the hospital was located on 15th Street. King George III granted the charter that established The New York Hospital in 1771; it is the second oldest hospital in the United States. The first patients, two Continental soldiers wounded in an attack against a British frigate in New York Harbor, were admitted in 1776. The New York Hospital-Cornell Medical Center (NYH-CMC) was established at its present location in 1932. The Payne Whitney Psychiatric Clinic also opened on this site in 1932, and has been an integral part of the medical center.
In 1997, a new hospital was built adjacent to Cornell Campus and named the Greenberg Pavilion of the NewYork-Presbyterian Hospital. It is an integral part of the Weill Cornell Medical Center Campus providing a wide array of acute and chronic medical issues, and resources for clinical researchers to carry out clinical research studies in their particular areas of interest. It is a one-million-square-foot hospital which connects to the medical school. With a state-of-the-art 880-bed inpatient facility with 50,000 square feet of emergency room space, it also has 19 high-technology operating rooms, intensive care units, labor and delivery suites, and neonatal and burn units. Recently, a newly renovated 16-bed unit was dedicated to hematopoietic stem cell transplantation.
Weill Medical College (WMC) is the birthplace of many medical advances among which are: the development of the Pap test for cervical cancer, the first organic synthesis of penicillin, the synthesis of oxytocin, the first successful embryo-biopsy pregnancy and birth in the U.S., and most recently, the world's first clinical trial for gene therapy for Parkinson's disease.
This legacy was fostered and accelerated under the leadership of Dean Antonio Gotto, JR through the Strategic Research Planning for the 21st Century, a program over the past 10 years that has focused on leadership, research and scholarship resulting in WMC’s position as one of the nation’s leading clinical and medical research institutions. Phase I and Phase II of the Strategic Research Planning were completed with an investment of over $1 billion in medical education, clinical care, and new research initiatives in such areas as structural biology, genetic medicine, and neuroscience. Several new facilities of excellence were initiated and include, the Lehman Brothers Lung Cancer Research Center, the Belfer Gene Therapy Core Facility and Institute of Hematology and Medical Oncology, the Milstein Program in Chemical Biology and Chemistry Core Facility, and the Prince Alwaleed Bin Talal Bin Abdulaziz Al-Saud Institute for Computational Biomedicine, the Ansary Center for Stem Cell Therapeutics. Other research initiatives have included children's health, cardiovascular medicine, neuroscience, women's health and geriatrics.
The initiatives have also resulted in collaborations with other medical institutions internationally. WMC in Qatar is the first American medical school ever established overseas. WMC is currently affiliated with a total of 10 international institutions, including The Bugando University College of Health Sciences and Medical Center in Tanzania, American Hospital of Paris, St. Luke's Medical Center in the Philippines and The Nightingale Hospital in Turkey.
Strategic Research Plan Phase III (Discoveries that Make a Difference), is now underway, and will further enhance translational research. Through 2011, a total investment of approximately $1.6 billion will be made with a large part directed to promoting translational research and accelerating discoveries.
